$1.36
1.49%
Nasdaq, Nov 28, 09:39 pm CET
ISIN
US68375N1037
Symbol
OPK

OPKO Health, Inc. Stock price

$1.36
-0.08 5.56% 1M
+0.06 4.62% 6M
-0.11 7.48% YTD
-0.22 13.92% 1Y
-0.04 2.86% 3Y
-3.28 70.69% 5Y
-9.58 87.57% 10Y
+0.90 195.65% 20Y
Nasdaq, Closing price Fri, Nov 28 2025
+0.02 1.49%

Key metrics

Basic
Market capitalization
$1.0b
Enterprise Value
$977.9m
Net debt
positive
Cash
$415.2m
Shares outstanding
768.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.6 | 1.7
EV/Sales
1.5 | 1.6
EV/FCF
negative
P/B
0.8
Financial Health
Equity Ratio
62.1%
Return on Equity
-3.9%
ROCE
-11.7%
ROIC
-16.0%
Debt/Equity
0.3
Financials (TTM | estimate)
Revenue
$642.1m | $604.6m
EBITDA
$-134.6m | $-121.8m
EBIT
$-213.8m | $-213.9m
Net Income
$-180.4m | $-265.3m
Free Cash Flow
$-212.1m
Growth (TTM | estimate)
Revenue
-9.8% | -15.2%
EBITDA
40.3% | 36.2%
EBIT
30.9% | 21.8%
Net Income
-34.9% | -398.4%
Free Cash Flow
-6.1%
Margin (TTM | estimate)
Gross
35.3%
EBITDA
-21.0% | -20.1%
EBIT
-33.3%
Net
-28.1% | -43.9%
Free Cash Flow
-33.0%
More
EPS
$-0.2
FCF per Share
$-0.3
Short interest
7.7%
Employees
3k
Rev per Employee
$240.0k
Show more

Is OPKO Health, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

OPKO Health, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a OPKO Health, Inc. forecast:

8x Buy
80%
2x Hold
20%

Analyst Opinions

10 Analysts have issued a OPKO Health, Inc. forecast:

Buy
80%
Hold
20%

Financial data from OPKO Health, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
642 642
10% 10%
100%
- Direct Costs 415 415
22% 22%
65%
227 227
27% 27%
35%
- Selling and Administrative Expenses 240 240
23% 23%
37%
- Research and Development Expense 122 122
29% 29%
19%
-135 -135
40% 40%
-21%
- Depreciation and Amortization 79 79
5% 5%
12%
EBIT (Operating Income) EBIT -214 -214
31% 31%
-33%
Net Profit -180 -180
35% 35%
-28%

In millions USD.

Don't miss a Thing! We will send you all news about OPKO Health, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OPKO Health, Inc. Stock News

Neutral
GlobeNewsWire
11 days ago
MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Piper Sandler 37th Annual Healthcare Conference, being held December 2-4, 2025 at the Lotte New York Palace Hotel in New York City. Management will be holding one-on-one meetings with investors and will be participating in a fireside discussion on Wednesday, Dece...
Neutral
Seeking Alpha
about one month ago
OPKO Health, Inc. ( OPK ) Q3 2025 Earnings Call October 29, 2025 4:30 PM EDT Company Participants Phillip Frost - Chairman & CEO Elias Zerhouni - President & Vice Chairman Adam Logal - Senior VP & CFO Gary Nabel - Chief Information Officer & Director Conference Call Participants Yvonne Briggs - LHA Investor Relations Maurice Raycroft - Jefferies LLC, Research Division Yi Chen - H.C. Wainwright ...
Neutral
GlobeNewsWire
about one month ago
MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights from the third quarter of 2025 and recent weeks include the following: Entered into a research collaboration with Regeneron Pharmaceuticals to develop multispecific antibodies.
More OPKO Health, Inc. News

Company Profile

OPKO Health, Inc. engages in the provision of healthcare services. It operates through the following segments: Diagnostics, Pharmaceuticals, and Corporate. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Head office United States
CEO Phillip Frost
Employees 2,997
Founded 1991
Website www.opko.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today